Get started
333

WITHUS PHARMACEUTICAL. CO., LTD

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

330350 chart


Full chart

Key stats


Market capitalization
‪92.66 B‬ KRW
Dividend yield (indicated)
1.42%
Price to earnings Ratio (TTM)
10
Basic EPS (TTM)
580 KRW
Net income (FY)
‪7.96 B‬ KRW
Revenue (FY)
‪80.12 B‬ KRW
Shares float
‪6.23 M‬
Beta (1Y)
0.65

Employees


Employees (FY)
206
Change (1Y)
+11 +5.64%
Revenue / Employee (1Y)
‪298.70 K‬ KRW
Net income / Employee (1Y)
‪29.67 K‬ KRW

About WITHUS PHARMACEUTICAL. CO., LTD


Sector
Health Technology
CEO
Dae-Young Sung
Headquarters
Seoul
Website
withuspharm.com
Founded
2004
ISIN
KR7330350000
FIGI
BBG00V3L19C7
Withus Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription drugs. Its products include drugs for the circulatory, musculoskeletal, and digestive systems, antibiotics, and vitamins. The company was founded on August 19, 2004 and is headquartered in Seoul, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 330350 is 6,980 KRW — it has increased by 0.14% in the past 24 hours. Watch WITHUS PHARMACEUTICAL. CO., LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange WITHUS PHARMACEUTICAL. CO., LTD stocks are traded under the ticker 330350.
330350 stock has fallen by −0.43% compared to the previous week, the month change is a −2.65% fall, over the last year WITHUS PHARMACEUTICAL. CO., LTD has showed a −21.57% decrease.
330350 reached its all-time high on Jul 3, 2020 with the price of 27,230 KRW, and its all-time low was 5,960 KRW and was reached on Oct 17, 2022. View more price dynamics on 330350 chart.
See other stocks reaching their highest and lowest prices.
330350 stock is 1.00% volatile and has beta coefficient of 0.65. Track WITHUS PHARMACEUTICAL. CO., LTD stock price on the chart and check out the list of the most volatile stocks — is WITHUS PHARMACEUTICAL. CO., LTD there?
Today WITHUS PHARMACEUTICAL. CO., LTD has the market capitalization of ‪92.00 B‬, it has decreased by −1.27% over the last week.
Yes, you can track WITHUS PHARMACEUTICAL. CO., LTD financials in yearly and quarterly reports right on TradingView.
330350 net income for the last quarter is ‪−271.90 M‬ KRW, while the quarter before that showed ‪2.02 B‬ KRW of net income which accounts for −113.47% change. Track more WITHUS PHARMACEUTICAL. CO., LTD financial stats to get the full picture.
Yes, 330350 dividends are paid annually. The last dividend per share was 100.00 KRW. As of today, Dividend Yield (TTM)% is 1.43%. Tracking WITHUS PHARMACEUTICAL. CO., LTD dividends might help you take more informed decisions.
WITHUS PHARMACEUTICAL. CO., LTD dividend yield was 1.03% in 2023, and payout ratio reached 16.57%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 8, 2024, the company has 206.00 employees. See our rating of the largest employees — is WITHUS PHARMACEUTICAL. CO., LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. WITHUS PHARMACEUTICAL. CO., LTD EBITDA is ‪12.12 B‬ KRW, and current EBITDA margin is 13.42%. See more stats in WITHUS PHARMACEUTICAL. CO., LTD financial statements.
Like other stocks, 330350 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WITHUS PHARMACEUTICAL. CO., LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So WITHUS PHARMACEUTICAL. CO., LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating WITHUS PHARMACEUTICAL. CO., LTD stock shows the sell signal. See more of WITHUS PHARMACEUTICAL. CO., LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.